Stockreport

Mesoblast Signs Deal In China For Stem Cell Heart Therapies [Seeking Alpha]

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com
PDF Summary Mesoblast Limited ( MESO ) announced yesterday that it had entered into a partnership with China based Tasly Pharmaceutical Group . The deal gives Tasly [Read more]